Lupus (SLE): Symptoms, Tests and When to Follow Up

Published: 1 October 2026 9 min read Dr. Shimaa Sherif

Medically reviewed by: Dr. Mohab Ashraf Fouad

This article was translated into English from the Arabic original and reviewed for medical accuracy.

Article illustration: Lupus (SLE): Symptoms, Tests and When to Follow Up

What does lupus mean, and who can develop it?

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. The immune system, whose normal role is to protect the body, mistakenly attacks the body's own tissues. The resulting inflammation can affect the skin, joints, blood, kidneys, lungs, heart or nervous system. “Systemic” means that more than one part of the body may be involved; it does not mean that every person will develop every symptom or organ complication [1, 6].

Anyone can develop lupus, during childhood or later in life, but it is more common in women and during the childbearing years. That information helps a clinician consider the possibility; it is not a diagnostic test. Men and older adults can also have lupus, while fatigue or a rash in a young woman is not enough to establish it. Diagnosis begins with a complete pattern of symptoms, examination and tests, not age or sex alone [1, 7].

The disease often has periods of activity, when symptoms increase or a new problem appears, and periods of remission, when symptoms ease or disappear. The pattern differs greatly between people and may change over time. A single day's picture therefore cannot tell the whole story. Recording when a rash or joint swelling appeared, whether it followed sun exposure, whether fever occurred, and whether urine changed gives the clinician more useful evidence than a general checklist found online [1, 2, 6].

Lupus symptoms in the skin, joints and energy levels

Lupus symptoms do not form one fixed list. Common features include persistent fatigue, fever without a clear cause, and painful or swollen joints with stiffness. A rash may cross the cheeks and bridge of the nose in a butterfly-like shape, or round rashes may appear elsewhere. Sun sensitivity, hair loss and usually painless sores in the mouth or nose can occur. Fingers may change colour in response to cold or stress, a feature called Raynaud's phenomenon [1, 7].

One of these symptoms does not automatically mean lupus. Fatigue has many causes, including poor sleep, anaemia, thyroid disorders and other illnesses. Joint pain also has several causes, and many skin conditions cause rashes. A combination of features from different body systems, symptoms that recur together, or an objective finding on examination or testing is more informative. Even the “butterfly” rash is not present in everyone with lupus, and not every red facial rash is caused by lupus [1, 6, 7].

Before an appointment, photograph a rash while it is visible if it may fade before the visit, and record which joints were visibly swollen and how long morning stiffness lasted. Distinguish general tiredness from breathlessness, and joint aching from visible joint swelling. If fatigue is the only symptom, assessing common causes is more useful than jumping directly to an autoimmune diagnosis. The linked article on vitamin D explains why fatigue alone does not identify one particular deficiency [2, 8].

Kidney, chest and neurological signs: when not to wait

Kidney involvement in lupus may not cause pain. Possible signs include noticeably foamy urine, blood in the urine, swelling in the legs, feet or around the eyes, and high blood pressure. Urine testing looks for protein and blood, while a blood test measures creatinine to estimate kidney function. A kidney biopsy is sometimes needed to confirm lupus nephritis and identify its pattern, but that decision follows the medical assessment and results; it is not required for everyone with lupus [3].

Contact a clinician promptly if you notice new persistent foam, visible blood, a marked reduction in urine or new swelling, especially with raised blood pressure. These facts explain why urine and blood-pressure monitoring remain important even when the skin and joints feel quiet. The linked articles on kidney stones and blood-pressure readings discuss other possible causes of these signs without assuming every change is due to lupus [2, 3].

Seek emergency care if you cannot breathe, have severe chest pain, or have symptoms that could represent a heart attack. New neurological symptoms such as a seizure, severe confusion, sudden weakness or altered consciousness also need urgent assessment. Lupus can be associated with inflammation around the heart or lungs and with neurological problems, but infection, blood clots and other conditions can produce a similar picture. Do not try to label the sign as a “lupus flare” at home or wait for an ANA result before being assessed [1, 6, 7].

Lupus diagnosis is not one test or a home score

No single test proves lupus by itself. A clinician connects the history over time with examination, blood and urine results, while excluding other conditions that can look similar. Questions about rashes and sun exposure, joint swelling, mouth sores, pain with breathing, medicines and family history matter. Examination may cover the skin, joints, heart, lungs and nervous system, after which targeted tests can be selected instead of ordering the same autoimmune “panel” for everyone [2, 6, 8].

Initial and targeted investigations may include a complete blood count for anaemia or low blood-cell counts, kidney function, urinalysis for protein or blood, and inflammation markers. Depending on the pattern, the clinician may request ANA, more specific antibodies, complement components C3 and C4, and antiphospholipid antibodies. Suspected organ involvement may require imaging or a skin or kidney biopsy. Each investigation answers a different question; a longer list is not automatically more accurate [2, 5, 8].

The 2019 EULAR/ACR criteria use a positive ANA on at least one occasion as an entry requirement, followed by weighted items from clinical and immunological domains. These are “classification criteria” developed to identify comparable groups for research; they should not become a self-diagnosis calculator. A clinician may use their framework, but clinical diagnosis still depends on the whole picture and excluding a more likely explanation. A criteria score or an app screenshot cannot replace an examination [2, 10].

ANA and more specific antibodies: what do results mean?

ANA is a sensitive lupus test: most people with lupus have a positive result, so a negative result makes lupus less likely. A positive ANA, however, is not a diagnosis. It can occur with other autoimmune diseases, some infections or medicines, and in healthy people. The result must be read alongside the reason for testing, symptoms and examination, not only the positive or negative flag [2, 4, 9].

When ANA is positive and the clinical story fits, the clinician may request anti-dsDNA and anti-Smith antibodies, which are more specific for lupus than ANA. Complement C3 and C4, antiphospholipid antibodies, a blood count, kidney function and urinalysis may also be appropriate. Selection changes with the symptoms: assessing possible kidney involvement asks different questions from investigating a rash, clotting or low platelets. More specialised tests should not be ordered randomly without a clear clinical question [2, 5, 10].

The ANA titre and pattern can add context, but the laboratory alone cannot decide whether the result explains the symptoms. Do not repeatedly test ANA simply because it is positive, and do not begin treatment from the result. If ANA is negative but there is an objective organ sign such as urine protein or documented joint swelling, the clinician reviews possible diagnoses and appropriate investigations rather than relying on one test. The clinical question and the trend in relevant results matter more than chasing every available antibody [2, 4, 9].

Why follow-up continues, with an important note on pregnancy

Lupus is chronic, and its activity can change after a quiet period. Regular follow-up reviews symptoms, examination, blood pressure, the blood count, kidney function and urine as appropriate for the individual, while also monitoring treatment effects. The aim is not to perform every test at every visit, but to detect an important change early and adjust the plan to disease activity and the affected organ. Do not stop a medicine or change its dose because symptoms have settled without speaking to the treating clinician [2, 12].

Between visits, record the flare features relevant to you, such as increasing fatigue, joint swelling, a rash, fever or a new headache, and report a change rather than waiting for a routine appointment if it is concerning. Sun protection is appropriate when sunlight triggers a rash, and every new medicine, herb or supplement should be reviewed for interactions and adverse effects. No special diet or supplement has been shown to treat lupus, so do not replace follow-up with an online remedy [1, 2].

If pregnancy is being considered, discuss the plan early with the rheumatology and obstetric teams before trying to conceive, and do not stop treatment on your own. Most women can have a successful pregnancy, but risk assessment and monitoring depend on lupus activity, kidney function, blood pressure, previous pregnancy and clotting history, and antibodies such as antiphospholipid and anti-SSA/Ro. Some medicines need review before pregnancy, and close monitoring during pregnancy is important for both mother and baby [2, 11].

Prepare for the visit and make the next step pattern-based

Before the visit, write a simple timeline: when each symptom started, how long it lasted, what made it worse, and whether it occurred with a rash, fever, joint swelling or urine change. Bring photographs of visible rashes, complete laboratory reports with their reference intervals, and older results for comparison. Prepare a list of all medicines and supplements, and mention a recent infection or a current or planned pregnancy. These details are more useful than requesting ANA without context [2, 8].

Ask clearly: which findings are objectively present, what other explanations are possible, what question will each requested test answer, and whether urine or kidney testing needs repeating. If a result is positive but symptoms are nonspecific, the useful question is not “Which treatment should I start?” but “Is there clinical evidence of autoimmune disease, and what follow-up is appropriate?” With a confirmed diagnosis, ask about your own flare signs and follow-up schedule instead of comparing your numbers with another person's [2, 4, 12].

When symptoms or results need structured interpretation, the medical team at La Rose can review the history, examination and tests and identify the appropriate next step, without assuming that a positive ANA equals lupus or that a negative ANA closes every possibility. La Rose has branches in Maadi and Fifth Settlement, New Cairo. For severe chest pain, difficulty breathing or new neurological symptoms, seek emergency care rather than waiting for a clinic appointment [3, 6]. For non-urgent concerns, you can book a consultation with the medical team.

Knowledge Centre

How this article was reviewed

This content is for health education and does not replace diagnosis or an individual care plan.

Author listed in record
Dr. Shimaa Sherif
Reviewer listed in record
Dr. Mohab Ashraf Fouad
Linked medical sources
12
Publication and review history
  1. Published: 1 October 2026
  2. 1 October 2026: We reviewed the article and updated its information for 2026.
  3. Review record: A reviewer is listed in the publication record
  4. Linked medical sources: 12

Frequently asked questions

There is no single first presentation for everyone. Lupus may begin with fatigue, fever without a clear cause, painful or swollen joints, a sun-sensitive rash, mouth sores or hair loss. These features overlap with many other conditions, so one symptom is not a diagnosis. The pattern, duration, examination findings and appropriate blood and urine results are what matter [1, 6, 7].

No. A positive ANA can occur with lupus, other autoimmune diseases, some infections or medicines, and in healthy people. A clinician relates it to symptoms and examination and may request anti-dsDNA or anti-Smith antibodies and targeted blood and urine tests. Do not start treatment or label yourself as having lupus from this result alone [2, 4, 9].

A negative result makes lupus less likely because most people with lupus have a positive ANA, but it is not a verdict separate from the clinical story. If an important objective sign is present, the clinician reviews the test method, alternative diagnoses and investigations suited to that sign. Do not repeat the test or select antibody panels on your own without a clear clinical question [2, 4, 10].

Test selection follows the symptoms. It often includes ANA, a complete blood count, kidney function and urinalysis. After a positive ANA with a compatible clinical story, the clinician may request anti-dsDNA, anti-Smith, C3, C4 and antiphospholipid antibodies. Imaging or a skin or kidney biopsy is sometimes needed. None of these diagnoses lupus away from the examination and complete picture [2, 5, 8].

Kidney involvement may not cause obvious pain, which is why urinalysis, kidney function and blood pressure are important in follow-up according to the clinician's plan. Foamy urine, blood in the urine, swelling or raised blood pressure need prompt contact. Biopsy is not routine for every patient; it is used when results suggest that identifying the kidney-injury pattern will guide decisions [2, 3].

Lupus is chronic and there is currently no cure, but long periods of remission are possible and treatment can control symptoms, reduce activity and protect organs. Follow-up continues because symptoms can change, urine or blood results may sometimes change before an obvious problem is felt, and treatment itself requires monitoring. Do not stop treatment on your own during a quiet period [2, 6, 12].

Written by

Dr. Shimaa Sherif

Specialist in Rheumatology, Joint Diseases, Physical Medicine and Rehabilitation

  • Specialist in rheumatology, joint diseases, physical medicine and rehabilitation
  • MSc in Rheumatology and Rehabilitation
  • Extensive experience in diagnosing and treating rheumatic diseases

Dr. Shimaa Sherif is a specialist in rheumatology, joint diseases, physical medicine and rehabilitation, with an MSc in Rheumatology and Rehabilitation and extensive experience in diagnosing and treating rheumatic diseases. She follows rheumatoid arthritis, lupus, joint and spinal osteoarthritis, gout and fibromyalgia, as well as scleroderma, Sjögren's syndrome and Behçet's disease. She also follows pregnancy in patients with rheumatoid arthritis and provides rehabilitation and physical medicine for joint patients.

View profile

You may also find helpful

Start with a real consultation - book now

Booking ahead is required. Patients are seen in order of arrival.